Integer Appoints James Flanagan and Aaron Kapito to Board of Directors

Core Viewpoint - Integer Holdings Corporation has appointed James Flanagan and Aaron Kapito as independent directors to its Board of Directors, enhancing its governance and strategic oversight as the company aims for sustainable long-term value creation [1][2]. Board Appointments - James Flanagan, former COO of PwC, brings 39 years of diversified financial and operational expertise [4]. - Aaron Kapito, co-founder of Politan Capital Management, has a strong background in investment management and serves on multiple boards [6]. Strategic Focus - The Board emphasizes the importance of the new directors' insights in executing Integer's strategic priorities and driving organic sales growth, expected to return to market levels in 2026 and exceed market levels in 2027 [2]. - Irenic Capital Management, which has invested in Integer, believes the company is well-positioned for growth in key markets and values the new directors' contributions to enhancing focus on growth and value creation [2][11]. Cooperation Agreement - A cooperation agreement between Integer and Irenic includes standard provisions such as standstill and voting rights, with details to be filed with the SEC [3]. Company Overview - Integer Holdings Corporation is a leading global medical device contract development and manufacturing organization, serving various markets including cardio and vascular, neuromodulation, and cardiac rhythm management [10]. - The company is recognized for its commitment to quality, service, and innovation, with brands like Greatbatch Medical and Lake Region Medical [10].